Home
Scholarly Works
A phase II study of UCN-01 in combination with...
Conference

A phase II study of UCN-01 in combination with topotecan in patients with advanced recurrent ovarian cancer: A Princess Margaret Phase II Consortium Trial

Authors

Hirte HW

Volume

23

Pagination

pp. 223S-223S

Publisher

AMER SOC CLINICAL ONCOLOGY

Publication Date

June 1, 2005

Name of conference

41st Annual Meeting of the American-Society-of-Clinical-Oncology

Conference place

Orlando, FL

Conference start date

May 13, 2005

Conference end date

May 17, 2005

Conference proceedings

JOURNAL OF CLINICAL ONCOLOGY

Issue

16

ISSN

0732-183X

Labels

Fields of Research (FoR)

Contact the Experts team